Skip to main content
. 2012 Oct;56(10):5070–5075. doi: 10.1128/AAC.00672-12

Fig 2.

Fig 2

Individual changes in the maximum plasma concentration (top) and the area under the concentration-time curve (bottom) of raltegravir alone versus raltegravir coadministered with ginkgo biloba. (Two subjects were excluded because the T1/2 and AUC0-∞ could not be determined.)